Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhenoBiome provides microbiome-based functional profiling assays (e.g., human gut microbiome assay GxGutHealth) and in vitro models to link gut microbiome metabolism with host physiology and disease; there is no evidence of formal therapeutic candidates in clinical trials yet, and the company is currently focused on diagnostics, research tools, and enabling technologies rather than its own clinical-stage drugs[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhenoBiome.